Individual isotoxic radiation dose escalation based on V20 and advanced technologies benefits unresectable stage III non-small cell lung cancer patients treated with concurrent chemoradiotherapy: long term follow-up

Under the assumption that the highest therapeutic ratio could be achieved by increasing the total tumor dose (TTD) to the limits of normal tissues, the phase I trial was conducted in patients with unresectable stage III non-small cell lung cancer treated with concurrent chemoradiotherapy, to determi...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Oncotarget
Hoofdauteurs: Liu, Ming, Wang, Zhongtang, Zhou, Tao, Zhou, Antang, Zhao, Qian, Li, Hongsheng, Sun, Hongfu, Huang, Wei, Li, BaoSheng
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Impact Journals LLC 2017
Onderwerpen:
Clinical Research Paper
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5584295/
https://ncbi.nlm.nih.gov/pubmed/28881694
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.16288
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items